Posts by: Diogo Pinto

News

Orofacial pain — continuous discomfort in the mouth, jaws, and face — can be fairly common and persistent in children with juvenile idiopathic arthritis (JIA), and sufficiently limiting to negatively ... Read more

June 22, 2018June 22, 2018

New Study to Determine if Arthritis Patients May Be Able to Successfully Reduce Medication

News

A new study by Canadian researchers will explore the possibility of reducing medication for arthritis patients whose disease has already been under control for a certain period of time. Arthritis ... Read more

June 11, 2018June 11, 2018

Adalimumab Shows Better Long-term Results than Infliximab for JIA-associated Uveitis, Study Finds

News

Adalimumab showed better long-term safety and efficacy results compared to infliximab in the treatment of juvenile idiopathic arthritis (JIA)-associated uveitis, or the inflammation of the eye’s middle layer, an Italian study reports. ... Read more

March 21, 2018March 21, 2018

Poor Growth in JIA Patients May Happen Soon After Disease Onset, Study Reports

News

Children with juvenile idiopathic arthritis (JIA) may experience impaired vertical growth in the first three years of the disease, according to researchers. The study, “Growth patterns in early juvenile idiopathic ... Read more

March 14, 2018March 14, 2018

Early Exposure to Cigarette Smoke, Air Pollution Associated with JIA, Study Finds

News

Exposure to cigarette smoke and harmful particles in the air during pregnancy and after birth were identified as potential risk factors for the development of juvenile idiopathic arthritis (JIA) in ... Read more

March 9, 2018March 9, 2018

Subcutaneous Orencia Seen to Alleviate Polyarticular-course JIA Symptoms in Phase 3 Trial

News

Abatacept, marketed as Orencia by Bristol-Myers Squibb, was seen to improve the symptoms of polyarticular-course juvenile idiopathic arthritis (pJIA) in a Phase 3 clinical trial. Additionally, subcutaneous administration of Orencia was ... Read more